Bell Richard, Pandanaboyana Sanjay, Upasani Vivek, Prasad Raj
Department of Hepatobiliary and Transplant Surgery, St James University Hospital, Leeds, UK.
Department of Hepatobiliary and Pancreatic Surgery, Auckland City Hospital, Auckland, New Zealand.
ANZ J Surg. 2018 May;88(5):415-420. doi: 10.1111/ans.14245.
This meta-analysis aimed to compare living donor liver transplantation (LDLT) grafts with a graft-to-recipient weight ratio (GRWR) of <0.8 to grafts with a GRWR ≥0.8 with regards to small-for-size syndrome (SFSS) and short and longer term outcomes.
An electronic search was performed of the MEDLINE, EMBASE and PubMed databases until December 2016 using both subject headings (MeSH) and free text. Pooled odds ratios and hazard ratios were calculated using fixed- and random-effects models for meta-analysis.
Eight studies including 1833 patients met the inclusion criteria. The rate of SFSS was 10% in the <0.8 group and 5% in the ≥0.8 group (odds ratio: 1.69 (1.09, 2.61) (P = 0.020)). No significant difference was noted between the two groups with regards to graft survival up to 5 years (hazard ratio: 1.31 (0.88, 1.94) (P = 0.190)). Similarly, no significant difference was noted in overall complications (P = 0.06), biliary (P = 0.290) or vascular complications (P = 0.190), perioperative haemorrhage (P = 0.150), post-operative mortality (P = 0.810) and rejection (P = 0.160).
The incidence of SFSS in grafts with a GRWR <0.8 is more than in GRWR ≥0.8; however, the low GRWR does not appear to impact perioperative outcomes or graft survival.
本荟萃分析旨在比较移植物与受体重量比(GRWR)<0.8的活体肝移植(LDLT)移植物和GRWR≥0.8的移植物在小体积综合征(SFSS)以及短期和长期预后方面的情况。
截至2016年12月,使用主题词(医学主题词)和自由文本对MEDLINE、EMBASE和PubMed数据库进行电子检索。使用固定效应模型和随机效应模型计算合并比值比和风险比以进行荟萃分析。
八项研究共纳入1833例患者,符合纳入标准。GRWR<0.8组的SFSS发生率为10%,GRWR≥0.8组为5%(比值比:1.69(1.09,2.61)(P = 0.020))。两组在5年移植物存活率方面无显著差异(风险比:1.31(0.88,1.94)(P = 0.190))。同样,在总体并发症(P = 0.06)、胆道并发症(P = 0.290)或血管并发症(P = 0.190)、围手术期出血(P = 0.150)、术后死亡率(P = 0.810)和排斥反应(P = 0.160)方面也无显著差异。
GRWR<0.8的移植物中SFSS的发生率高于GRWR≥0.8的移植物;然而,低GRWR似乎并未影响围手术期结局或移植物存活率。